Effect of Combination Chemotherapy of Afatinib, Pemetrexed and Gemcitabine on Advanced Non-small Cell Lung Cancer and Its Influence on Tumor Markers, Immune Function and Quality of Life

JIA Jing; XUE Ying-jie; WU Yang

doi:10.3969/j.issn.1002-3429.2020.10.013

Home>Articles>Effect of Combination Chemotherapy of Afatinib, Pemetrexed and Gemcitabine on Advanced Non-small Cell Lung Cancer and Its Influence on Tumor Markers, Immune Function and Quality of Life

DOI: 10.3969/j.issn.1002-3429.2020.10.013

Effect of Combination Chemotherapy of Afatinib, Pemetrexed and Gemcitabine on Advanced Non-small Cell Lung Cancer and Its Influence on Tumor Markers, Immune Function and Quality of Life

JIA Jing

XUE Ying-jie

WU Yang

Machine-generated Keywords：

Publication Date：2020-10-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 53-57 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2020,33(10)